What is really inside the Ingestion , Injectable , vaccines and what do they do in the body ?
(From the book, "What The Pharmaceutical Companies Don't Want You To Know About Vaccines" - By Dr.odd M. Elsner)
IF YOU VACCINATE In the first 6 years of life your child receives the following:
•17,500 mcg 2-phenoxyethanol (antifreeze)
•5,700 mcg aluminum (neurotoxin)
•Unknown amounts of fetal bovine serum(aborted cow blood)
•801.6 mcg formaldehyde (carcinogen, embalming agent)
•23,250 mcg gelatin (ground up animal caucuses)
•500 mcg human albumin (human blood)
•760 mcg of monosodium L-glutamate (causes obesity & diabetes)
•Unknown amounts of MRC-5 cells (aborted human babies)
•Over 10 mcg neomycin (antibiotic)
•Over 0.075 mcg polymyxin B (antibiotic)
•Over 560 mcg polysorbate 80 (carcinogen)
•116 mcg potassium chloride (used in a lethal injection)
•188 mcg potassium phosphate (liquid fertilizer agent)
•260 mcg sodium bicarbonate (baking soda)
•70 mcg sodium borate (Borax, used for cockroach control)
•54,100 mcg of sodium chloride (table salt)
•Unknown amounts of sodium citrate (food additive)
•Unknown amounts of sodium hydroxide (Danger! Corrosive)
•2,800 mcg sodium phosphate (toxic to any organism)
•Unknown amounts of sodium phosphate monobasic monohydrate (toxic to any organism)
•32,000 mcg sorbitol (Not to be injected)
•0.6 mcg streptomycin (antibiotic)
•Over 40,000 mcg sucrose (cane sugar)
•35,000 mcg yeast protein (fungus)
•5,000 mcg urea (metabolic waste from human urine)
•Other chemical residuals
🚨HUNDREDS of studies now indicate COVID-19 “vaccines” are one of the LARGEST carcinogenic exposures in history.
They:
1. Increase your risk of 7 major cancers
2. Disrupt THOUSANDS of critical genes
3. Integrate into human genomes
4. Drive genome instability
5. Enable tumor immune escape
6. Suppress DNA repair mechanisms
7. Drive chronic inflammation
8. Cause immune dysregulation (↓T-cells, ↓type I IFN)
9. Disrupt microRNA networks controlling growth/apoptosis
10. Activate oncogenic signaling (MAPK, PI3K/AKT/mTOR)
11. Remodel the tumor microenvironment
12. Reactivate dormant cancers
13. Block innate immune sensing (TLR inhibition)
14. Produce aberrant proteins (frameshift errors)
15. Induce immune exhaustion
16. Promote IgG4 class switching
17. Contain plasmid DNA including SV40
18. Disrupt RAS signaling → oxidative stress + proliferation
19. Damage the microbiome(loss of immune balance)
20. Increase treatment resistance
Shocking Findings: mRNA Vaccines Trigger Deep Gene Expression Changes, Mitochondrial Damage, and Possible DNA Integration
A new peer-reviewed study published in the Journal of American Physicians and Surgeons raises important concerns about the biological effects of mRNA vaccines.
The paper, titled "Gene Expression Alterations Induced by mRNA Vaccines," was authored by Nicolas Hulscher, Dr. Peter A. McCullough, and Dr. John Catanzaro.
It reviews evidence from transcriptomics, proteomics, and genomics studies in humans.
The authors conclude that mRNA vaccines cause broad and coordinated changes in gene expression that go well beyond short-term immune responses or inflammation.
Among the main findings are the following:
* Transcriptomic analysis of individuals who developed new adverse events or cancers after vaccination revealed major disruptions in key cellular pathways. These included impaired mitochondrial function, reduced ribosome activity, problems with protein breakdown systems, altered control of protein synthesis, and widespread changes in metabolism. Although some inflammation-related signals were detected, they accounted for only a small fraction of the total alterations, suggesting a deeper rewiring of gene regulation.
* In a longitudinal study of healthy people who received mRNA vaccines, 214 out of 342 measured plasma proteins showed significant changes over 24 weeks. The most pronounced shifts occurred between 16 and 24 weeks after vaccination and involved systems related to complement activation, metabolic regulation, hormone signaling, and vitamin and cofactor pathways. These findings indicate effects that persist much longer than many earlier assumptions suggested.
* A case study of a patient who developed aggressive stage IV bladder cancer following mRNA vaccination identified abnormal activity in cancer-related genes such as KRAS, PIK3CA, and ATM, along with weakened DNA repair processes and evidence of genomic instability. Tumor DNA also contained a sequence matching part of the vaccine's spike protein coding region, raising questions about possible integration of vaccine-derived genetic material into human DNA.
The authors point out that mRNA technology—first used in COVID-19 vaccines and now being developed for cancer, influenza, RSV, and other applications—was introduced without required long-term monitoring of gene expression, genomic integration, or built-in mechanisms to halt unwanted activity.
They state that without mandatory molecular surveillance, enforceable safety controls, and biological safeguards to prevent harmful gene expression changes, mRNA vaccine platforms remain inherently dangerous to humans.
They call for an immediate and complete suspension of their use in people.
These findings challenge the earlier view that mRNA vaccines produce only brief and localized effects.
While the results need confirmation through additional independent studies, they demonstrate a clear need for detailed, ongoing genomic and proteomic monitoring in anyone who receives these products.
Health authorities and regulators should review this evidence openly and prioritize safety data that extends beyond immediate immune reactions.
💉💉💉 The CIA used vaccines as a cover for mind control experiments
✅ "Project Artichoke" exposes the infamous MK-ULTRA project, and sheds light on the shocking methods of intelligence agencies in the 1950s:
* What was Project Artichoke - This is a secret CIA program designed to test whether a person could be made to perform actions (including murder) against their will through hypnosis, drugs and chemicals.
* The connection to vaccines and drugs - The CIA sought "discreet" ways to introduce mind-altering substances into the population. One of the methods tested was the use of vaccines and routine medical products as a "Trojan horse" to introduce psychoactive drugs, without the subjects knowing that they were participating in the experiment.
* Blurring ethical boundaries - The documents show that the agency collaborated with scientists and medical institutions to develop substances that cannot be detected in regular blood tests, in order to control human behavior and erase memories.
✅ The participants of the "experiment" suffered from:
* Complete lack of awareness - Most of the participants (who included prisoners, psychiatric patients, and even soldiers) did not even know that they were part of an experiment. They thought they were receiving regular medical treatment or a vaccine.
* Severe mental damage - Many of them suffered nervous breakdowns, amnesia (memory loss), psychotic attacks, and chronic anxiety following the combination of hypnosis and drugs like LSD
* Death and physical injuries - There were cases of death and irreversible brain damage.
* Abuse and humiliation - Some of the experiments involved sleep deprivation, electric shock, and extreme isolation to "break" the subject's personality and rebuild it as an "agent" or someone who could be controlled.
💥 Cover-up: The CIA went to great lengths to destroy documents in the 1970s, so many of the victims never received recognition, compensation, or even an explanation for what happened to them.
The covid vaccines were never about immunization, they are full of biosensor technology.. and they work well enough to be reused for other biosensing applications after expiration..
This paper explains a "practical" and "innovative" idea: instead of discarding expired protein-based COVID-19 vaccines, their spike proteins can be repurposed and reused as sensitive biological tools for antibody testing. The researchers focused on expired Novavax vaccines and showed that even more than a year after their expiration date, the spike proteins inside them are still structurally intact and biologically active. By attaching these proteins to a gold sensor surface and using a highly sensitive optical method to monitor binding in real time, they demonstrated that antibodies from vaccinated or previously infected individuals still bind strongly and specifically to the expired vaccine proteins. They carefully measured how tightly these antibodies attach and found the interactions remain in a high-affinity range, comparable to commercially produced laboratory-grade spike proteins. In simple terms, the study shows that expired vaccines don’t necessarily lose their scientific usefulness — their active ingredients can still function as reliable components in diagnostic biosensors, turning what would be medical waste into a sustainable tool for monitoring immune responses.
Provided below is a section-by-section overview of the paper:
"The second life for unused COVID-19 vaccines: Towards biosensing application"
https://www.sciencedirect.com/.../pii/S003991402500133X
1. Abstract
The paper proposes repurposing expired COVID-19 vaccines (EXVAX) for biosensing applications instead of discarding them. Specifically, expired Novavax (protein-based) vaccines containing recombinant SARS-CoV-2 spike (S) protein are used as sensing elements to detect antibodies in human serum.
Key findings:
• Expired vaccines retain biologically active spike protein even more than one year past expiration.
• They can be immobilized on gold sensor chips.
• They show high-affinity antibody binding (nanomolar range KD values).
Results were validated using both:
• TIRE (Total Internal Reflection Ellipsometry) for real-time kinetic measurements.
• ELISA for cross-validation.
The work supports sustainability goals by reducing vaccine waste.
2. Introduction
This section explains:
The Problem
• Massive vaccine overproduction during COVID-19.
• Large quantities expired unused.
• Disposal creates waste and sustainability concerns.
• Lower-income countries often receive short shelf-life vaccines.
Proposed Solution
Use expired vaccines for biosensing, specifically:
• Detecting antibodies in serum.
• Monitoring immunity.
• Supporting serological testing.
Focus on Novavax (Protein-Based Vaccine)
• Contains recombinant full-length spike protein.
• Adjuvanted with Matrix-M (saponin nanoparticles).
• Spike protein is structurally intact and stable.
• Lower reactogenicity compared to mRNA vaccines → higher unused stock accumulation.
Biosensing Context
The paper explains:
• Biosensors rely on antigen-antibody recognition.
• Common methods include ELISA.
Advanced label-free techniques (like TIRE) provide:
• Real-time kinetics
• Affinity constants
• Thermodynamic analysis
The authors propose comparing:
• Expired vaccine spike protein (EXVAX)
• Commercial recombinant wild-type spike (SCoV2-S)
• Omicron spike variant (SCoV2-oS)
3. Materials and Methods
This section describes the experimental setup.
3.1 EXVAX Preparation
• Expired Novavax vaccine concentrated ~10-fold.
• Buffer exchanged to DPBS.
• Ultrafiltration used.
• Final spike concentration adjusted.
3.2 ELISA Testing
• Plates coated with EXVAX antigen.
Human sera tested:
• Previously infected individual
• Vaccinated individuals (Comirnaty, Vaxzevria)
• Antibody titers measured.
• Apparent dissociation constants (KD) calculated using sigmoidal curve fitting.
3.3 Surface Functionalization
Gold sensor chips:
• Cleaned.
• Coated with 11-MUA self-assembled monolayer (SAM).
• Activated with NHS/EDC chemistry.
• Spike proteins covalently immobilized.
• Blocked with ethanolamine (MEA).
Three surfaces prepared:
1. SCoV2-S
2. SCoV2-oS
3. EXVAX
3.4 Immune Complex Formation
• Diluted human sera injected.
• Real-time interaction monitored.
• Regeneration step performed with glycine (pH 3).
3.5 TIRE Setup
• Spectroscopic ellipsometer used.
• Measured (amplitude ratio) and A (phase shift).
• Sensitive to thickness and refractive index changes.
• Allows label-free, real-time monitoring.
4.1 Evaluation of EXVAX by ELISA
Findings:
• Expired vaccine binds human antibodies effectively.
• High affinity observed (picomolar KD range).
Stability maintained even:
• 7 months post-expiration
• 1.5 years post-expiration
Conclusion: Spike protein remains functional long after expiration.
4.2 Covalent Immobilization on Gold Surface
TIRE monitored immobilization kinetics.
Findings:
• Wild-type and Omicron recombinant proteins show strong signal shifts.
EXVAX shows smaller signal change due to:
• Lower spike concentration.
• Adjuvant (saponin) adsorption/desorption.
• MEA blocking removes loosely adsorbed adjuvant.
Thermodynamic analysis:
• All immobilizations are thermodynamically favorable.
• EXVAX shows slightly lower AGbind but still stable.
Conclusion: Expired vaccine can be successfully immobilized.
4.3 Human Serum Interaction
Diluted sera from:
• Previously infected person.
• Vaccinated individuals.
Findings:
• Strong immune complex formation observed.
• KD values in nanomolar range (10-11 to 10-9).
• EXVAX performs similarly to recombinant spike.
• Omicron variant shows lower affinity due to RBD mutations.
• Non-specific binding was low.
Conclusion: EXVAX works comparably to commercial spike proteins.
4.4 Mathematical Modeling of Kinetics
Two-step binding model applied:
• Accounts for encounter complex formation.
Calculates:
• ka (association rate)
• kd (dissociation rate)
• KA, KD
• AGbind (Gibbs free energy)
Key results:
• High affinity immune complexes.
• EXVAX and wild-type spike show comparable thermodynamic profiles.
• All interactions are energetically favorable.
Sensitivity to refractive index:
• Highest for SCoV2-S
• Slightly lower for EXVAX (due to lower protein density).
5. Conclusions
This is the first demonstration that:
• Expired protein-based COVID vaccines can be repurposed for biosensing.
• Spike protein remains biologically active long after expiration.
• EXVAX can be immobilized and detect antibodies effectively.
• High-affinity immune complexes form (KD between 10-11 and 10-9).
• Strategy supports sustainable development by reducing vaccine waste.
The authors suggest:
• Expired vaccines could be used in serological testing.
• Vaccine production could align with circular economy principles.
Overall What This Paper Is Saying
Instead of discarding expired Novavax COVID-19 vaccines, their spike proteins can be reused as functional biological recognition elements in antibody biosensors. These expired vaccines retain structural integrity, bind antibodies with high affinity, and can be integrated into advanced optical sensing systems like TIRE.
This transforms vaccine waste into a reusable biomedical diagnostic material.
How can Covid tests be classified as injectable devices?.. Watch until the end to see...
This patent describes a technology where tiny, flexible electronic systems can be injected into tissue using a syringe or injection device, allowing electronics to integrate into soft environments with less invasiveness than traditional implants. The core innovation is combining nanoscale wires with injectable delivery methods so electronics can function inside living or soft materials after insertion.
Provided below is a section-by-section overview of the patent:
"Systems and methods for injectable devices"
https://patents.google.com/patent/US20170172438A1/en
1. Title / What the Patent Is About
This patent describes tiny electronic devices that can be injected into soft materials — especially biological tissue — using a syringe/needle or injection device. The goal is to place electronic components inside tissue with minimal surgery.
The invention focuses on nanoscale wires and flexible electronics that can survive injection and still function afterward. In simple terms:
Instead of implanting large hardware surgically, this idea is to inject electronics like a fluid.
2. Background / Problem Being Solved
The patent explains that traditional implants can be:
• invasive to insert,
• damaging to tissue,
• rigid and mechanically mismatched with soft biological environments.
The inventors aim to solve this by designing devices that are:
• extremely small and flexible,
• injectable through needles,
• able to integrate with soft tissue.
This creates a less traumatic way to introduce electronics into living svstems.
3. Abstract (Core Idea in Plain Language)
The abstract says the invention involves:
• electronic devices containing nanoscale wires,
• delivery through a syringe or needle,
• insertion into soft matter such as biological tissue or polymers,
• optional connection to external circuits or computers after injection.
Plain-language version:
Tiny wire-based electronics are injected into tissue, where they can then communicate with external systems.
4. Summary of the Invention
This section describes the main concepts:
Key ideas include:
• Injectable electronics that fold or compress for insertion.
• Devices that expand or function once inside tissue.
Systems that may include:
• sensors,
• conductive wires,
• fluid carriers,
• or cellular components.
The patent also mentions kits and methods for making and using these systems.
(Covid test kits?)
5. Device Structure (How It Works)
The patent discusses components such as:
> Nanoscale Wires
• Ultra-thin conductive structures.
• Designed to interface with biological environments.
> Flexible Mesh or Network
• Electronics can form soft networks that move with tissue instead of fighting it.
> Injection Medium
• Fluid or carrier material helps deliver the device through a needle.
> External Connections
After injection, devices may:
• connect to external circuitry,
• transmit electrical signals,
• potentially interface with computers or measurement systems
6. Methods of Use (What the Patent Describes Doing)
The patent outlines methods such as:
• loading the device into a syringe,
• injecting into tissue or soft materials,
• allowing the structure to deploy internally,
• connecting it electrically afterward.
Potential environments include:
• biological tissue,
• polymer matrices,
• engineered materials.
7. Figures & Diagrams (What They Usually Show)
The drawings generally illustrate:
• syringe-based delivery systems,
• nano-wire meshes entering tissue,
• device configurations before and after injection,
• pathways for external electrical connection.
These diagrams help explain how electronics can pass through narrow needles without breaking.
8. Claims (What Is Legally Protected)
The claims focus on protecting:
• injectable electronic structures,
• nanoscale wire configurations,
• delivery methods through needles,
• systems combining electronics with fluids or biological materials.
The broad idea protected is:
→ Injecting functioning electronic devices into soft matter rather than surgically implanting them.
9. Applications Mentioned or Implied
The patent suggests potential uses such as:
• biological sensing,
• recording electrical signals,
• interfacing with tissues,
• research tools for studying biological systems.
Important note: patents often list broad possible uses to cover future development.
Why this patent matters (big-picture context)
This work fits into a broader research direction often called:
• injectable bioelectronics,
• soft biointerfaces,
• nanoelectronic tissue integration.
It represents a shift from rigid implants → minimally invasive injectable systems.
This paper is a 2020 review exploring how bio-nano interface technology—the interaction between biomolecules (DNA, RNA, proteins) and nanomaterials—could be applied across the entire COVID-19 response, from prevention to diagnosis, vaccines, and treatment, describing how nanoscale science might influence viral detection, immune responses, and therapeutic delivery; it explains the SARS-CoV-2 life cycle and transmission, surveys historical advances in nanoscience and virology, and then details proposed or emerging nanotech applications such as graphene- and plant-extract-coated masks, antimicrobial surfaces, nanoparticle-based vaccine carriers and adjuvants, nano-enabled PCR/CRISPR and biosensor diagnostics, cytokine-adsorbing materials, nanobody antibodies, and targeted drug-delivery systems to the lungs, ultimately arguing that bio-nano approaches could provide versatile tools to improve pandemic preparedness, testing, immunization strategies, and antiviral therapies.
Provided below is a section-by-section overview of the paper:
The Perspective on Bio-Nano Interface Technology for Covid-19
https://www.frontiersin.org/.../fnano.2020.586250/full
Paper Overview (Front Matter)
The paper is a 2020 Frontiers in Nanotechnology review that explores how bio-nano interface science-the interaction between biomolecules and nanomaterials-could contribute to COVID-19 prevention, diagnosis, vaccines, and treatment. It frames nanotechnology as a tool for PPE, diagnostics, vaccine delivery systems, and antiviral therapies.
INTRODUCTION
Defines bio-nano interfaces as interactions between nanoscale materials and biological systems.
Key points:
• Biomolecules like DNA, RNA, and proteins function naturally at the nanoscale.
• Nanotechnology can mimic or influence biological processes.
• Applications include implantable devices and nano-robots.
• The author proposes that virus-human DNA/ RNA interactions occur at the nanoscale and that nanotech could help combat COVID-19.
• Introduces the idea of a plant-extract/ graphene "bio-nano composite mask" that could trap and inactivate virus particles.
LIFE CYCLE OF COVID-19
Explains viral infection and replication steps:
• Spike protein binds ACE2 receptors; TMPRSS2 enables membrane fusion.
• Viral RNA is released, translated, assembled, and released via exocytosis.
• Notes particle size (50-200 nm), aerosol transmission, and surface persistence.
• Discusses protein-protein interaction mapping between viral and human proteins.
• Mentions drug-screening efforts and early FDA-approved or trialed compounds.
• Describes incubation period, viral shedding, and comparison with SARS/MERS.
Figures illustrate:
Viral replication cycle.
Nanocarriers that could target different infection stages.
INSPIRATION FROM VIROLOGY IN NANOSCIENCE
Historical review of how virology and nanoscience evolved together:
• Discovery of viruses (Tobacco mosaic virus).
• Development of electron microscopy.
• Protein crystallography and DNA structure.
• Coining of "nanotechnology."
• Cryo-EM studies revealing SARS-CoV-2 spike protein structure.
• Nanopore sequencing for rapid virus detection.
Positions bio-nano science as crucial for understanding virus structure and designing antivirals.
BIO-NANO INTERFACE TECHNOLOGY TOWARD COVID-19
Explains how nanomaterials interact with biological systems:
• Factors include surface charge, shape, chemistry, and surrounding media.
• These interactions affect uptake, trafficking, and immune responses.
° Mentions patent-filing activity for COVID-related nanotech.
• Introduces three major application areas: Prevention, Vaccines, Diagnosis, Treatment.
PREVENTION
Self-Disinfecting Surfaces
• Nanocoatings in PPE can add hydrophobic and antimicrobial properties.
• Metal nanoparticles (Ag, Au, TiO2, ZnO) and polymers are discussed.
• Light-activated nanocrystals that generate reactive oxygen species are proposed for viral inactivation.
• Respiratory Masks
• Reviews cloth mask effectiveness.
• Proposes graphene + plant-extract coated masks to trap and deactivate virus.
Lists existing nano-mask products:
• Copper-oxide nanofibers
• Graphene inks
• TiO2/Ag photocatalytic masks
• Nanofiber membranes
Claims some designs are washable, reusable, or sunlight-activated.
VACCINES
Discusses:
Traditional vaccine types (attenuated, inactivated, protein subunits).
Challenges:
• Spike-protein design
• Mutation rates
• Immune enhancement risks
• Animal models
• Duration of immunity
Nanoparticle Vaccine Platforms:
Explains nanoparticles as:
• Antigen carriers
• Adjuvants
Types listed:
• Liposomes
• Polymer particles
• Virus-like particles
• Carbon nanotubes
• Lipid nanoparticles (LNPs)
• Cites Moderna's LNP-mRNA platform and other early clinical trials.
Vaccine Adjuvant Nanoparticles:
• Nanoparticles themselves may stimulate immunity and reduce antigen dose.
Includes a large WHO-style table listing 2020 clinical-trial vaccine candidates by:
• Platform
• Developer
• Trial phase
IMMUNOMODULATION WITH NANOMATERIALS
Focuses on cytokine storms and lung damage:
• Mentions IL-6 blockers (tocilizumab, siltuximab).
Proposes nanocarriers to:
• Deliver immunosuppressants
• Adsorb cytokines
• Target immune cells
• Carbon nanomaterials and nanodiamonds are cited for IL-6/TNF-a adsorption.
DIAGNOSIS
Molecular Tests:
Describes:
• RT-PCR
• RT-LAMP
• Gene targets (E, N, RdRP).
• Sample collection from respiratory tract.
CRISPR Diagnostics:
• Cas12/Cas13 systems.
• SHERLOCK assays for viral RNA
Nano-Enabled Sensors:
• Gold nanoparticle colorimetric tests.
• Plasmonic nano-islands for ultra-sensitive detection.
• Graphene FET biosensors coated with spike antibodies.
• Serological Tests
• IgM/IgG detection.
• Lateral-flow strips with gold nanoparticles.
• ELISA and CLIA.
Notes false positives and WHO caution on early point-of-care use.
TREATMENT
Discusses:
• Viral targets (proteases, RdRP, ACE2).
• Al-assisted drug discovery.
Nanocarriers for:
• Improved solubility
• Targeted lung delivery
• Sustained release
• Pulmonary Delivery
• Mucoadhesive nanoparticles to penetrate lung mucus.
Nanobodies:
• Camelid-derived antibodies.
• Example: nebulized nanobody Nb11-59.
Drug Repurposing + Nanoformulations:
• Hydroxychloroquine liposomes.
• Combination drug nanoparticles.
• CRISPR-Cas antiviral approaches delivered by nanocarriers.
• Cytokine-storm control using nano-adsorbents.
Overall Theme
The paper argues that bio-nano interface technologies-including graphene materials, nanoparticles, nano-vaccines, biosensors, and nanocarriers-could play a major role across the entire COVID-19 response pipeline, from PPE and testing to vaccines and therapies.
🔴 High levels of glyphosate found in MMR vaccine 🔴
There is a huge increase in chronic diseases. And we are concerned about glyphosate in our food, but what about injecting it directly into our bodies or our children's bodies?
So 5 vaccines were tested:
💉Flu, 💉Pneumococcus,
💉Hepatitis B,
💉MMR, 💉Tdap
And it was found that the MMR vaccine had 25 times higher levels of glyphosate than other vaccines tested.
Glyphosate is a widely used non-selective herbicide. It is also defined as a highly carcinogenic substance. Its injection leads to local tissue destruction, systemic poisoning, nausea, vomiting, diarrhea, the development of cancerous tumors and death. .
â—¾A link to the full report is in the comments of the post